Tech Company Financing Transactions
Agilvax Funding Round
On 8/1/2014, Agilvax raised $2 million in Series A funding from private investors.
Transaction Overview
Company Name
Announced On
8/1/2014
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series A
Investors
Proceeds Purpose
The new funding will also allow the company to develop new products.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5901 Indian School Rd. Northeast
Albuquerque, NM 87110
USA
Albuquerque, NM 87110
USA
Phone
Website
Email Address
Overview
Agilvax develops targeted vaccine therapies based on its proprietory virus-like particle (VLP) platform technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Patti
Chief Financial Officer
Dee Brescia
Chief Operating Officer
Les Stewart
VP - Bus. Development
Michael Perrine
VP - R & D
Jerri Caldeira
Browse more venture capital transactions:
Prev: 8/1/2014: LensAR venture capital transaction
Next: 8/1/2014: Contactually venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs